CGTX
Cognition Therapeutics, Inc.
$1.9
Earnings Summary
Revenue | $0Mn |
Net Profits | $-8.14Mn |
Net Profit Margins | -Inf% |
Highlights
Cognition Therapeutics, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Cognition Therapeutics, Inc. has generated NaN% jump in its revenue since last 3-months.
Cognition Therapeutics, Inc.’s net profit fell -174.2% since last year same period to $-8.14Mn in the Q4 2023. On a quarterly growth basis, Cognition Therapeutics, Inc. has generated -20.63% fall in its net profits since last 3-months.
Cognition Therapeutics, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Cognition Therapeutics, Inc. has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Cognition Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.25 |
EPS Estimate Current Year | -0.25 |
Highlights
Cognition Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a 26.47% jump from last quarter’s estimates.
Cognition Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.25.
Key Ratios
Key ratios of the Cognition Therapeutics, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.27 |
Highlights
Cognition Therapeutics, Inc.’s earning per share (EPS) fell -35% since last year same period to -0.27 in the Q4 2023. This indicates that the Cognition Therapeutics, Inc. has generated -35% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-02 | -0.24 | -0.22 | 8.33% |
2023-08-08 | -0.19 | -0.16 | 15.79% |
2023-05-04 | -0.18 | -0.21 | -16.67% |
2024-03-26 | -0.34 | -0.27 | 20.59% |
₹0 US Stocks a/c Opening Fee